Literature DB >> 30292241

Correction to: The role of fibrinolysis inhibition in engineered vascular networks derived from endothelial cells and adipose-derived stem cells.

Severin Mühleder1,2, Karoline Pill1,2, Mira Schaupper1,2,3, Krystyna Labuda1,2, Eleni Priglinger1,2, Pablo Hofbauer4, Verena Charwat5, Uwe Marx6, Heinz Redl1,2, Wolfgang Holnthoner7,8.   

Abstract

The original article [1] contains numerous value errors in the graphs in Fig. 2b regarding the markers describing the values for total tubule length and mean tubule length without aprotinin at 2.5 mg/ml concentration of fibrinogen. The corrected version of this figure can be viewed ahead.

Entities:  

Year:  2018        PMID： 30292241      PMCID： PMC6174062          DOI： 10.1186/s13287-018-1001-3

Source DB:  PubMed          Journal:  Stem Cell Res Ther        ISSN： 1757-6512            Impact factor:   6.832


  1 in total

1.  The role of fibrinolysis inhibition in engineered vascular networks derived from endothelial cells and adipose-derived stem cells.

Authors:  Severin Mühleder; Karoline Pill; Mira Schaupper; Krystyna Labuda; Eleni Priglinger; Pablo Hofbauer; Verena Charwat; Uwe Marx; Heinz Redl; Wolfgang Holnthoner
Journal:  Stem Cell Res Ther       Date:  2018-02-12       Impact factor: 6.832
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.